Assessment of the efficacy and safety of fampridine
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Sociedad Española de Farmacia Hospitalaria
2017
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876463453579771904 |
|---|---|
| author | Beatriz Mejuto |
| author_facet | Beatriz Mejuto |
| contents | Assessment of the efficacy and safety of fampridine Beatriz Mejuto Paloma Castellano Concepción Castro Luis Manuel López Medicina Safety Efficacy Fampridine Multiple sclerosis Objective: Assessment of the efficacy and safety of fampridine for walking improvement in adult patients with multiple sclerosis. Method: A descriptive retrospective study of all patients who initiated treatment with fampridine between March, 2014 and February, 2015. Efficacy was assessed through the 25-foot walk test and the 12-item walking scale for multiple sclerosis. It was reviewed whether patients had suffered any of the most frequent adverse effects described in the pivotal clinical trial.Results: Six patients were included, with a 66.7% response rate. At 3-6 months, the mean change in walking speed (compared to baseline) was 39.32% and there was a mean improvement of 15 points in the walking scale. Only one patient presented adverse effects. Conclusions: The results obtained are encouraging, particularly when fampridine is the only drug currently approved to control such a disabling symptom as instability while walking. 2017 artículo científico 1130-6343 https://www.redalyc.org/articulo.oa?id=365962268009 https://www.redalyc.org/journal/3659/365962268009/ https://www.redalyc.org/journal/3659/365962268009/html/ https://www.redalyc.org/journal/3659/365962268009/365962268009.epub https://www.redalyc.org/journal/3659/365962268009/movil 10.7399/fh.2017.41.2.10615 en http://www.redalyc.org/revista.oa?id=3659 Farmacia Hospitalaria application/pdf Sociedad Española de Farmacia Hospitalaria Farmacia Hospitalaria (España) Num.2 Vol.41 |
| format | Artículo científico |
| id | redalyc_365962268009 |
| institution | Redalyc |
| language | en |
| publishDate | 2017 |
| publisher | Sociedad Española de Farmacia Hospitalaria |
| spellingShingle | Assessment of the efficacy and safety of fampridine Beatriz Mejuto Medicina Safety Efficacy Fampridine Multiple sclerosis Assessment of the efficacy and safety of fampridine Beatriz Mejuto Paloma Castellano Concepción Castro Luis Manuel López Medicina Safety Efficacy Fampridine Multiple sclerosis Objective: Assessment of the efficacy and safety of fampridine for walking improvement in adult patients with multiple sclerosis. Method: A descriptive retrospective study of all patients who initiated treatment with fampridine between March, 2014 and February, 2015. Efficacy was assessed through the 25-foot walk test and the 12-item walking scale for multiple sclerosis. It was reviewed whether patients had suffered any of the most frequent adverse effects described in the pivotal clinical trial.Results: Six patients were included, with a 66.7% response rate. At 3-6 months, the mean change in walking speed (compared to baseline) was 39.32% and there was a mean improvement of 15 points in the walking scale. Only one patient presented adverse effects. Conclusions: The results obtained are encouraging, particularly when fampridine is the only drug currently approved to control such a disabling symptom as instability while walking. 2017 artículo científico 1130-6343 https://www.redalyc.org/articulo.oa?id=365962268009 https://www.redalyc.org/journal/3659/365962268009/ https://www.redalyc.org/journal/3659/365962268009/html/ https://www.redalyc.org/journal/3659/365962268009/365962268009.epub https://www.redalyc.org/journal/3659/365962268009/movil 10.7399/fh.2017.41.2.10615 en http://www.redalyc.org/revista.oa?id=3659 Farmacia Hospitalaria application/pdf Sociedad Española de Farmacia Hospitalaria Farmacia Hospitalaria (España) Num.2 Vol.41 |
| title | Assessment of the efficacy and safety of fampridine |
| topic | Medicina Safety Efficacy Fampridine Multiple sclerosis |
| url | https://www.redalyc.org/articulo.oa?id=365962268009 https://www.redalyc.org/journal/3659/365962268009/ https://www.redalyc.org/journal/3659/365962268009/html/ https://www.redalyc.org/journal/3659/365962268009/365962268009.epub https://www.redalyc.org/journal/3659/365962268009/movil |